Plasma endothelin-1 release in normal and varicose saphenous veins

Angiology

Volumn 48, Issue 9, 1997, Pages 769-774

  Mangiafico, Roberto Antonio ^a   Malatino, Lorenzo Salvatore ^a   Santonocito, Maurizio ^a   Spada, Rosario Sebastiano ^a   Benedetto, Francesco Antonio ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1;

ADULT; ARTICLE; BLOOD LEVEL; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; SAPHENOUS VEIN; SMOOTH MUSCLE FIBER; VARICOSIS; VEIN OCCLUSION; VENOCONSTRICTION;

EID: 0030853727     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331979704800903     Document Type: Article

References (38)

1. Michiels C, Arnould T, Knott I, et al: Stimulation of prostaglandin synthesis by human endothelial cells exposed to hypoxia. Am J Physiol 264:C866-C874, 1993.
2. Arnould T, Michiels C, Remacle J: Increased PMN adherence on endothelial cells after hypoxia: Involvement of PAF, CD18/CD11b, and ICAM-1. Am J Physiol 264:C1102-C1110, 1993.
3. Arnould T, Michiels C, Remacle J: Hypoxic human umbilical vein endothelial cells induce activation of adherent polymorphonuclear leukocytes. Blood 83:3705-3716, 1994.
4. Michiels C, De Leener F, Arnould T, et al: Hypoxia stimulates endothelial cells to release smooth muscle cell mitogens: Role of prostaglandins and bFGF. Exp Cell Res 213:43-54, 1994.
5. Michiels C, Arnould T, Janssens D, et al: Interactions between endothelial cells and smooth muscle cells after their activation by hypoxia. A possible etiology for venous disease. Int Angiol 15:124-130, 1996.
6. Levin ER: Endothelins. N Engl J Med 333:356-363, 1995.
7. Lerman A, Edwards BS, Hallett JW, et al: Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 325:997-1001, 1991.
8. Morise T, Takeuchi Y, Takeda R, et al: Increased plasma endothelin levels in Kawasaki disease: A possible marker for Kawasaki disease. Angiology 9:719-723, 1993.
9. Morise T, Tacheuchi Y, Kawano M, et al: Increased plasma levels of immunoreactive endothelin and von Willebrand factor in NIDDM patients. Diabetes Care 18:87-89, 1995.
10. Davenport AP, Ashby MJ, Easton P, et al: A sensitive radioimmunoassay measuring endothelin-like immunoreactivity in human plasma: Comparison of levels in patients with essential hypertension and normotensive control subjects. Clin Sci 78:261-264, 1990.
11. Yoshizumi M, Kurihara H, Morita T, et al: Interleukin 1 increases the production of endothelin-1 by cultured endothelial cells. Biochem Biophys Res Commun 166:324-329, 1990.
12. Kourembanas S, Marsden PA, McQuillan LP, et al: Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest 88:1054-1057, 1991.
13. Ohlstein EH, Nichols AJ: Rabbit polymorphonuclear neutrophils elicit endothelium-dependent contraction in vascular smooth muscle. Circ Res 65:917-924, 1989.
14. Boulanger C, Lüsher TF: Release of endothelin from the porcine aorta: Inhibition by endothelium-derived nitric oxide. J Clin Invest 85:587-590, 1990.
15. Simonson MS, Dunn MJ: The molecular mechanisms of cardiovascular and renal regulation by endothelin peptides. J Lab Clin Med 267:119:622-639, 1992.
16. Farre AL, Riesco A, Espinosa G, et al: Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart. Circulation 88:1166-1171, 1993.
17. 2 formation. Angiology 39:1036-1042, 1988.
18. 2 and prostacyclin inhibit the production and the secretion of endothelin from cultured endothelial cells. J Biol Chem 269:11938-11944, 1994.
19. Schini VB, Hendrickson H, Heublein DM, et al: Thrombin enhances the release of endothelin from cultured porcine aortic endothelial cells. Eur J Pharmacol 165:333-334, 1989.
20. Kurihara H, Yoshizumi M, Sugiyama T, et al: Transforming growth factor-β stimulates the expression of endothelin mRNA by vascular endothelial cells. Biochem Biophys Res Commun 159:1435-1440, 1989.
21. Sharefkin J, Diamond S, Eskin S, et al: Fluid flow decreases preproendothelin mRNA levels and suppresses endothelin-1 peptide release in cultured human endothelial cells. J Vasc Surg 14:1-9, 1991.
22. Miller VM, Burnett JC Jr: Modulation of NO and endothelin by chronic increases in blood flow in canine femoral arteries. Am J Physiol 263:H103-H108, 1992.
23. MacArthur H, Warner TD, Wood KG, et al: Endothelin-1 release from endothelial cells in culture is elevated both acutely and chronically by short periods of mechanical stretch. Biochem Biophys Res Commun 200:395-400, 1994.
24. Wagner OF, Christ G, Woita J, et al: Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 267:16066-16068, 1992.
25. Vane JR, Botting RM: Impact of risk factors on the endothelium. Cardiovasc Risk Factors 4:108-121, 1994.
26. Thulesius O: The varicose saphenous vein functional and ultrastructural studies, with special reference to smooth muscle. Phlebology 3:89-95, 1988.
27. Yang Z, Richard V, von Segesser L, et al: Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm? Circulation 82:188-195, 1990.
28. Nwasokwa ON: Coronary artery bypass graft disease. Ann Intern Med 123:528-545, 1995.
29. Gorny P: Les excés de la "philosophie" conservatrice dans la chirurgie des varices. Phlébologie 48:303-305, 1995.
30. Gorny PH, Deloche A, Fabiani JN, et al: Réinterventions après pontage saphène aorto-coronarien. Arch Mal Coeur Vaisseaux 78:31-36, 1985.
31. Mellière D, Cales B, Martin-Jonathan C, et al: Nécessité de concilier les objectifs du traitment des varices et de la chirurgie artérielle. J Mal Vasc 16: 171-178, 1991.
32. MacFarlane R, Godwin RJ, Barabas AP: Are varicose veins and coronary artery bypass surgery compatible? Lancet 2:859, 1985.
33. Miranda C, Meyer P, Fabre M, et al: Tentative de mise au point d'une classification anatomo-clinique de références des varices des membres inférieurs. Artères et Veines 12:365-373, 1993.
34. Costello KB, Stewart DJ, Baffour R: Endothelin is a potent constrictor of human vessels used in coronary revascularization surgery. Eur Pharmacol 186:311-314, 1990.
35. Mann JM, McIntosh CL, Roberts WC: Spasm of saphenous veins used as conduits for aortocoronary bypass grafting. Am J Cardiol 15:1000-1002, 1987.
36. D'Souza VJ, Velasquez G, Kahl FR, et al: Spasm of the aortocoronary venous graft. Radiology 151:83-84, 1984.
37. Angelini GD, Brechenridge IM, Psaila JV, et al: Preparation of human saphenous vein for coronary artery bypass grafting impairs its capacity to produce prostacyclin. Cardiovasc Res 21:28-33, 1987.
38. Angelini GD, Christie MI, Bryan AJ, et al: Surgical preparation impairs release of endothelium-derived relaxing factor from human saphenous vein. Ann Thorac Surg 48:417-420, 1989.